×
About 15,023 results

ALLMedicine™ Papillomavirus Center

Research & Reviews  5,432 results

Killer cell immunoglobulin-like receptor (KIR) gene contents: Are they associated with ...
https://doi.org/10.1002/jmv.27873
Journal of Medical Virology; Tembhurne AK, Maheshwari A et. al.

May 21st, 2022 - Killer cell immunoglobulin-like receptors (KIRs) are required for natural killer cell function against virus-infected cells or tumor cells. KIR gene content polymorphisms in Indian women with cervical cancer (CaCx) remain unexplored. Hence, we ana...

Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carci...
https://doi.org/10.1002/cncr.34266
Cancer Huang SH, Jacinto JCK et. al.

May 20th, 2022 - The objective of this study was to describe the clinical presentation and outcomes of human papillomavirus (HPV)-positive nasopharyngeal cancer (NPC) versus Epstein-Barr virus (EBV)-positive NPC and HPV-positive oropharyngeal cancer (OPC). Clinica...

Additional parameters to improve the prognostic value of the 8th edition of the UICC cl...
https://doi.org/10.1002/hed.27084
Head & Neck; Straetmans JMJAA, Stuut M et. al.

May 18th, 2022 - The prognostic reliability of the UICC's TNM classification (8th edition) for human papillomavirus (HPV)-positive tonsillar squamous cell carcinomas (TSCCs) compared to the 7th edition was explored, and its improvement by using additional anatomic...

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the internat...
https://doi.org/10.1186/s12967-022-03383-x 10.1016/j.ejca.2009.07.016 10.1093/annonc/mdp471 10.1002/ijc.21955 10.3390/v10120729 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10.1136/bmj.g130 10.1016/S0140-6736(07)61450-0 10.3310/hta13510 10.1016/j.ygyno.2007.07.021 10.1016/S0140-6736(13)62218-7 10.1002/ijc.24010 10.1016/j.cmi.2020.03.033 10.1016/j.jcv.2015.10.023 10.1371/journal.pone.0210997 10.1186/s13104-018-3252-6 10.1002/ijc.28834 10.1038/sj.bjc.6606040 10.1186/s12885-018-4165-4 10.1186/1471-2407-14-207 10.1038/bjc.2015.11 10.1186/s12885-015-1804-x 10.1371/journal.pmed.0050132 10.1016/j.jcv.2013.06.041 10.1001/jama.287.16.2114 10.1002/path.1433 10.1002/sim.1213 10.1016/j.canep.2014.01.004 10.2147/IJWH.S56307 10.1200/jgo.2016.005629 10.1016/j.jcv.2018.08.006 10.1186/s12885-016-2246-9 10.1186/s12913-017-2160-0 10.1186/s12905-017-0490-z 10.1016/S1470-2045(13)70570-9 10.1136/sti.2004.011858 10.1002/sim.4780081110 10.1158/1055-9965.EPI-12-0953-T 10.1186/s12885-015-1126-z 10.1186/1471-2288-9-5 10.1016/j.cmi.2017.05.020 10.1186/s12885-015-1223-z 10.1186/s12885-016-2518-4 10.1371/journal.pone.0086835 10.1038/bjc.2013.22 10.1054/bjoc.2000.1375 10.1158/1055-9965.EPI-20-1538
Journal of Translational Medicine; Avian A, Clemente N et. al.

May 18th, 2022 - According to international guidelines, Human Papillomavirus (HPV) DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical in...

A Recent Advancement In Nanotechnology Approaches For The Treatment Of Cervical Cancer.
https://doi.org/10.2174/1871520622666220513160706
Anti-cancer Agents in Medicinal Chemistry; Hegde YM, Theivendren P et. al.

May 17th, 2022 - Cervical cancer is one of the leading causes of female death, with a mortality rate of over 200,000 per year in developing countries. . Despite a decrease in cervical cancer occurrences in developed countries over the last decade, the frequency of...

see more →

Guidelines  22 results

ASCCP Risk-Based Colposcopy Recommendations Applied in Thai Women With Atypical Squamou...
https://doi.org/10.1097/AOG.0000000000003982
Obstetrics and Gynecology; Phianpiset R, Ruengkhachorn I et. al.

Aug 10th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...

Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
https://doi.org/10.1097/AOG.0000000000004000
Obstetrics and Gynecology;

Aug 1st, 2020 - Human papillomavirus (HPV) causes significant morbidity and mortality in women and men. The HPV vaccine significantly reduces the incidence of anogenital cancer and genital warts in women and in men. Human papillomavirus vaccines are among the mos...

Cervical cancer screening for individuals at average risk: 2020 guideline update from t...
https://doi.org/10.3322/caac.21628
CA: a Cancer Journal for Clinicians; Fontham ETH, Wolf AMD et. al.

Jul 31st, 2020 - The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV te...

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideli...
https://doi.org/10.3322/caac.21616
CA: a Cancer Journal for Clinicians; Saslow D, Andrews KS et. al.

Jul 9th, 2020 - The American Cancer Society (ACS) presents an adaptation of the current Advisory Committee on Immunization Practices recommendations for human papillomavirus (HPV) vaccination. The ACS recommends routine HPV vaccination between ages 9 and 12 years...

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncolog...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418593
International Journal of Gynecological Cancer : Official ... Ciavattini A, Delli Carpini G et. al.

Jun 4th, 2020 - European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.|...

see more →

Drugs  3 results see all →

News  544 results

Shift to HPV Testing Will Require Public Education
https://www.medscape.com/viewarticle/974261

May 19th, 2022 - The shift from Papanicolaou (Pap) cytology to direct testing for the human papillomavirus (HPV) represents a major advance in cervical cancer screening. Nevertheless, some experts like Emily Delpero, MD, of Mount Sinai Hospital in Toronto, Canada,...

Imiquimod Cream Offers Alternative to Surgery for Vulvar Lesions
https://www.medscape.com/viewarticle/974096

May 17th, 2022 - Imiquimod cream is a safe, effective, first-line alternative to surgery for the treatment of vulvar high-grade squamous intraepithelial lesions (vHSILs), suggest the results from the first randomized trial to compare the two approaches directly. T...

HPV Strains Covered by the Vaccine Have Declined Greatly in the US
https://www.medscape.com/viewarticle/974084

May 16th, 2022 - Twelve years after the human papillomavirus (HPV) vaccination program was introduced in the United States, the overall prevalence of cancer-causing HPV strains covered by the vaccine dropped by 85% among females — 90% among vaccinated females and ...

Topical Imiquimod as Good as Surgery for Vulvar Intraepithelial Neoplasia
https://www.medscape.com/viewarticle/972953

May 2nd, 2022 - NEW YORK (Reuters Health) - Topical imiquimod works just as well as surgery for the first-line treatment of women with vulvar high-grade squamous intraepithelial lesions (vHSILs) — a precancerous lesion commonly caused by human papillomavirus (HPV...

One HPV Vaccine Dose Prevents Cervical Cancer: WHO
https://www.medscape.com/viewarticle/971933

Apr 12th, 2022 - LONDON (Reuters) - A single dose of human papillomavirus (HPV) vaccine is enough to protect against cervical cancer, a World Health Organization group of experts has said. At the moment, two- or three-dose regimens are recommended, but following a...

see more →

Patient Education  8 results see all →